National Cancer Institute Think-Tank Meeting Report on Proteomic Cartography and Biomarkers at the Single-Cell Level: Interrogation of Premalignant Lesions.
Saved in:
| Title: | National Cancer Institute Think-Tank Meeting Report on Proteomic Cartography and Biomarkers at the Single-Cell Level: Interrogation of Premalignant Lesions. |
|---|---|
| Authors: | Kagan J; Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States., Moritz RL; Institute for Systems Biology, Seattle, Washington, United States., Mazurchuk R; Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States., Lee JH; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States., Kharchenko PV; Blavatnik Institute for Biomedical Information, Harvard Medical School, Boston, Massachusetts, United States., Rozenblatt-Rosen O; Klarman Cell Observatory, Broad Institute, Boston, Massachusetts, United States., Ruppin E; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States., Edfors F; Science for Life Laboratory, KTH - Royal Institute of Technology, SE-171 21 Stockholm, Sweden., Ginty F; Life Sciences and Molecular Diagnostics Laboratory, GE Global Research Center, Niskayuna, New York, United States., Goltsev Y; Department of Microbiology and Immunology, Baxter Laboratory in Stem Cell Biology, Stanford University, Stanford Medical School, Stanford, California, United States., Wells JA; Department of Pharmaceutical Sciences, University of California, San Francisco, California, United States., LaCava J; Laboratory of Cellular and Structural Biology, Rockefeller University, New York, New York, United States., Riesterer JL; Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, Oregon, United States., Germain RN; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States., Shi T; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, United States., Chee MS; Encodia, Inc., San Diego, California, United States., Budnik BA; Faculty of Arts & Sciences, Division of Science. Harvard University, Boston, Massachusetts, United States., Yates JR 3rd; Department of Molecular Medicine, Scripps Research Institute, La Jolla, California, United States., Chait BT; Laboratory of Mass Spectrometry and Gaseous Ion Chemistry, The Rockefeller University, New York, New York, United States., Moffitt JR; Boston Children's Hospital and Harvard University Medical School, Boston, Massachusetts, United States., Smith RD; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, United States., Srivastava S; Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States. |
| Source: | Journal of proteome research [J Proteome Res] 2020 May 01; Vol. 19 (5), pp. 1900-1912. Date of Electronic Publication: 2020 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101128775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-3907 (Electronic) Linking ISSN: 15353893 NLM ISO Abbreviation: J Proteome Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
